patients showed fluctuating toxic confusional psychosis with lucid intervals and no neurological signs. Other workers including Henson et al. (1954) have also noticed early mental changes not attributable to metastases. (b) Subacute cerebellar degeneration: This is a relatively uncommon form of carcinomatous neuromyopathy but the clinical picture is striking (Brain & Wilkinson 1965) . Over the course of a few weeks, or occasionally days, the patient develops severe bilateral disturbances of cerebellar function producing inability to stand, gross ataxia of the arms and severe dysarthria so that the speech becomes almost unintelligible. There may also be mental disturbances. In a severe case the patient may be so disabled that he is unable to sit up in bed. The primary growth is most frequently a bronchial carcinoma but it is of interest that carcinoma of the ovary is the next most common responsible neoplasm. The CSF often shows changes including pleocytosis and slight rise of protein with a paretic Lange. (c) Brain-stem lesions: In this group of patients with carcinoma there is evidence of damage to the brainstem and spinal cord and post-mortem examination reveals histopathological evidence of extensive inflammatory lesions.
The wide variation of symptoms and signs found in this group is the result of the differing distribution and severity of lesions in the nervous system. The duration of the neurological illness varies considerably and in our series was from five to twenty months. In some cases the symptoms cease to progress and the patient may remain in an unchanged neurological state for several months, while on the other hand patients with severe involvement of bulbar or spinal motor neurones may show a progressive course until death.
Clinical Syndromes by P B Croft BM MRCP THE MYELOPATHIES
The spinal cord is involved in several types of carcinomatous neuromyopathy and may be the primary site of damage to the nervous system. Cord changes are found in association with subacute cerebellar degeneration, and in patients with encephalomyelitis due to carcinoma. Secondary changes in the cord may occur, the most striking example of which is the Wallerian degeneration in the posterior columns of patients with sensory neuropathy, who may also have involvement of the anterior horn cells.
Motor Neurone Disease
We have recently described a small group of patients in whom a neurological disorder closely resembling motor neurone disease occurs in association with various types of growth (Brain et al. 1965) . The clinical features are largely indistinguishable from those of classical motor neurone disease, having a combination of upper and lower motor neurone symptoms and signs, though the disease runs a rather more benign course than classical motor neurone disease. One patient in this group showed an unexpected improvement in his neurological disorder following removal of the bronchial carcinoma, but eventually died from the effects of cerebral metastases.
It might be argued that the occurrence of motor neurone disease and a major malignant disorder in the same patient is no more than a coincidence. A review of 86 patients with classical motor neurone disease showed only one patient in whom an unconfirmed carcinoma of the lung may have been present in the terminal stages. Norris & Engel (1965) found 13 (10%) patients with major malignant disorders in 130 patients with motor neurone disease, but this figure is very much higher than that found by other workers.
The recognition of this type of neuromyopathy makes it imperative to try to exclude possible malignant disease in patients with the symptoms and signs suggesting motor neurone disease. A chest X-ray should be done as a routine, and any atypical clinical features should reinforce the need for further investigations. If a tumour is found, the presence of an apparently incurable neurological disorder should not be regarded as a contraindication to surgical or other possible treatment of the carcinoma. Subacute Necrotic Myelopathy This is a very rare form of myelopathy associated with malignant disease in which there is massive necrosis in the cord (Mancall & Rosales 1964) . As with other types of carcinomatous neuromyopathy, the patient may be known to have a carcinoma before the neurological disorder develops, or the neurological symptoms may precede the discovery of the growth which may not be found until post-mortem examination is made. The patient develops subacutely an ascending sensorimotor myelopathy which usually does not extend above the dorsal cord though occasionally the cervical region is involved. The paraplegia is generally flaccid with loss of reflexes and the patient frequently dies within two months. The findings in the cerebrospinal fluid are variable, there being in some cases an increase of cells or protein, possibly associated with a paretic Lange, while in others the fluid is normal. THE 
NEUROPATHIES
The two main types of neuropathy encountered in association with malignant disease are sensory neuropathy and peripheral sensorimotor neuropathy. These present widely contrasting clinical pictures.
Sensory Neuropathy (Ganglioradiculitis) This is one of the less common varieties of carcinomatous neuromyopathy but the clinical syndrome is a dramatic one. No examples were seen in routine examination of patients with carcinoma, but of a selected group of 66 patients referred because of carcinomatous neuromyopathy, sensory neuropathy occurred in 8 (12 %). In threequarters of our cases bronchial carcinoma, usually of the oat-cell type, was discovered (Croft etal. 1965) .
The clinical course is subacute and the disability reaches its maximum in a few months and thereafter remains unchanged, though the patient may in the final stages of the illness develop moderate muscular weakness and mental disturbance. One of our patients was unusual in that a severe sensory neuropathy developed overnight and remained virtually unchanged for many months until the patient died. The clinical disability is severe but not always symmetrical. There may be backache in the early stages and the patient may have distressing paresthesiae in the limbs. However, the main disability is the development of a gross sensory ataxia which cripples the patient. Power is normal though the patient has difficulty in using his muscles as a result of the virtual deafferentation of the limbs. Tendon reflexes are lost and extensive sensory loss occurs affecting all forms of sensation both superficial and deep. At first the loss may be of segmental distribution, but tends to become universal, affecting all limbs and the trunk though not necessarily symmetrically. The CSF protein tends to be raised in the active stage of the disease with levels as high as 200 mg/100 ml. The neurological symptoms often occur well before any symptoms of neoplasm are present. Sometimes the underlying carcinoma is only confirmed at autopsy, though it may have been suspected for many months. The interval between the onset of neurological symptoms and death of the patient varied between six months and two years.
Like other types of carcinomatous neuromyopathy the exact pathogenic mechanism remains obscure. It is of interest that of the patients in whom specific anti-brain antibodies in sera and cerebrospinal fluid were found by Wilkinson (1964) all but one had a sensory neuropathy.
Peripheral Sensorimotor Neuropathy This type of neuropathy is much more common than the pure sensory neuropathy. Of 162 patients with various types of carcinomatous neuromyopathy, sensorimotor neuropathy was found in 36 (22%). In a recent study (Croft et al. 1967) we have found it possible to divide the patients into three groups: (1) Patients known to have a carcinoma may develop mild symptoms of peripheral neuropathy in the terminal stages of their illness. In such patients the neuropathy does not add greatly to the patient's disability. (2) In this group, the peripheral neuropathy is a severe disorder of subacute and occasionally acute onset and the patient often presents with neurological symptoms.
(3) Here the clinical features are similar to those in the second, but the neuropathy follows a remitting and sometimes relapsing course. As with other types of carcinomatous neuromyopathy the clinical pictures tend to be mixed and peripheral sensorimotor neuropathy may occur in association with other forms.
The range of neoplasms is much wider in sensorimotor neuropathy than in the pure sensory neuropathy. Carcinoma of the lung again predominates, but accounts for only about 50 %. Of the 17 patients who had carcinoma of the lung, the growth was of the oat-cell variety in 10 and of these 7 were women. Other growths included breast, stomach, colon, pancreas, body of the uterus, cervix, together with disorders such as Hodgkin's disease, malignant lymphoma and reticulum cell sarcoma of the pelvis.
Although the numbers are small it is of interest that of the patients in the remitting and relapsing group, only one had a bronchial carcinoma. It is too early to say whether this is a chance finding or whether there is some particular property of an oat-cell carcinoma which makes remission of the peripheral neuropathy less likely than when it is produced by some other type of growth.
In the patients with terminal neuropathy the signs were those of a straightforward mild peripheral neuropathy affecting mainly the lower limbs with some degree of weakness, peripheral impairment of sensation and diminished tendon reflexes.
In some patients with subacute sensorimotor neuropathy, symptoms of malignant disease had been present up to a year before the neuropathy developed, while in others the neuropathy was present for a considerable time before there was any evidence of associated malignant disorder. The longest interval between the development of neurological symptoms and discovery of the malignant disease was three years and ten months.
In a group of 8 patients the peripheral neuropathy showed a conspicuous clinical improvement and in some cases one or more subsequent relapses. In 3 there was a single episode of neuropathy followed by a marked improvement and no subsequent relapse. In one of these the improvement took place shortly after removal of the bronchial carcinoma, the patient subsequently dying from the effect of long-standing ischamic heart disease. In the 2 others the neurological improvement coincided with a course of steroid therapy. In another patient a single episode of neuropathy improved over a period of a few months' treatment with steroids, but two-and-aquarter years later she was found to have a carcinoma of the uterus, and while undergoing hysterectomy had an episode of suxamethonium chloride apncea.
Three patients had more than one episode of neuropathy, one who earlier had had a mastectomy having four distinct episodes. In this patient, throughout the neurological illness which lasted two-and-a-half years, chest X-rays showed shadows in the lungs which at post-mortem were confirmed as metastases. Her first episode of neuropathy improved on steroids, but in later attacks recovery occurred without steroids. Other patients proved unresponsive to steroid therapy.
As in the patients with sensory neuropathy, the CSF protein may be considerably raised in those with sensorimotor peripheral neuropathy, the highest level found being 360 mg/100 ml. There was a tendency for the protein to be higher in the acute stages of the disease, and to fall when the condition became quiescent or improved. The cell count was rarely significantly raised, but sometimes the Lange was paretic, though this did not necessarily coincide with a high CSF protein level.
Electrodiagnostic tests have shown reduction in the motor conduction velocity in peripheral nerves, while electromyography gave evidence of denervation.
A few patients showed disturbance of glucose metabolism. One presented with a severe peripheral neuropathy and was found to have a diabetic retinopathy and a considerably raised blood sugar. He was treated with insulin, at first requiring very large amounts to control the diabetes. Over succeeding months the suspicious shadow at one hilum proved to be a bronchial carcinoma, and as this became more evident, his insulin requirements fell. This is a point of theoretical interest since, although no special tests were made, it is possible that the tumour was producing a substance with insulin-like activity.
The striking difference in the natural history of the irreversible sensory neuropathy and the occasionally remitting peripheral sensorimotor neuropathy is presumably related to the site of the lesion. When severe neuronal loss occurs, as in ganglioradiculitis it is improbable that any significant improvement could occur; while where the disorder is in part at least due to segmental demyelination, the possibilities of recovery are much greater.
THE MUSCULAR DISORDERS

Polymyopathy
Some have denied the existence of a specific carcinomatous myopathy, and tended to attribute the muscle wasting found in association with malignant disease to the non-specific effects of cachexia, and in other patients to dermatomyositis. However, there is now fairly general agreement that there exists a disorder which in the Brain-Adams classification is termed polymyopathy. These patients develop subacutely fairly symmetrical proximal weakness and wasting of the muscles of the shoulder and pelvic girdles. Difficulty in rising from a chair or in mounting stairs may be an early symptom. Tendon reflexes are diminished or lost, though frequently the ankle-jerks are preserved. The patients may also show symptoms of fatigability suggesting myasthenia.
The muscular weakness may antedate the discovery of the carcinoma by months and even years. Shy & Silverstein (1965) estimate that in men developing proximal muscle weakness after the age of 50, the chance of some form of remote malignant disease is 60 %, while in women of the same age it is only 18 %.
In some patients with proximal weakness and wasting it may be difficult to decide whether one is dealing with a primary muscle disorder or a motor neuropathy. In such patients 'neuromuscular disorder' is a convenient descriptive term. Electrodiagnostic tests suggest that in some of these patients a motor neuropathy is present. In others there is no electrical evidence of denervation, motor conduction velocity is normal, and the EMG shows myopathic changes (Moody 1965).
Myasthenia
Myasthenia may be associated with proximal myopathy. There may be a clear clinical picture of myasthenia, though with several important differences from typical myasthenia gravis. Thus there tends to be less involvement of the bulbar muscles, while in the limb muscles there may be obvious wasting and loss of tendon reflexes which does not occur in true myasthenia gravis. In addition the patient may have parmsthesix indicating involvement of sensory neurones, while the clinical response to neostigmine and edrophonium chloride is less complete than in myasthenia gravis and sensitivity to decamethonium is greater. Guanidine is more effective than the anticholinesterase drugs. This myopathic-myasthenic syndrome is now often called the Eaton-Lambert syndrome in view of their description in 1957 of the electrophysiological changes, which include marked post-tetanic facilitation.
Like patients with myasthenia gravis, those with a myasthenic type of carcinomatous myopathy are abnormally sensitive to muscle relaxant drugs. This raises important practical considerations in anxsthesia and we have seen a number of patients in whom the use of relaxant drugs has unmasked a latent and largely subclinical neurological disorder. Patients who have shown slight weakness of the limbs before admission may become extensively paralysed for long periods after the use of relaxant drugs and occasionally a fatal outcome may ensue (Croft 1958) . Thus any patient suspected of having a carcinomatous myopathy should be investigated either without the use of relaxant drugs or after clinical testing for sensitivity to them.
Polymyositis and Dermatomyositis
It has been known for over twenty years that there is an association between dermatomyositis and malignant disease. The incidence of malignant disease in patients with this type of disorder varies in different series between about 2 % and 17%. All shades of clinical picture have been described between dermatomyositis, and, on the one hand, polymyositis with no evidence of skin involvement, and on the other primary systemic sclerosis (scleroderma). The latter has been noted to have an association with alveolar cell carcinoma (Montgomery et al. 1964) . In the patients with myositis there may be muscle pain and tenderness, the proximal muscles of the limb girdles and the neck and bulbar muscles being particularly involved.
The Endocrine Disorders
Apart from the more purely neurological manifestations produced remotely by various types of malignant disease, endocrine and metabolic disturbances may occur. These have been described in association with many different types of malignant disease, although as with the neurological disturbances, there is a particular association with oat-cell carcinoma of the bronchus. Time does not permit a full discussion of these syndromes, which include the ectopic ACTH (adrenocorticotrophic hormone) syndrome, hyponatrwmic syndrome, hypercalcmemia, hypoglycmmia, the carcinoid syndrome, skin pigmentation, thyrotoxicosis, and gynaccomastia. The ectopic ACTH syndrome: Some patients develop a biochemical disturbance resembling Cushing's syndrome and this disorder is now often termed the 'ectopic ACTH syndrome ' (Liddle et al. 1965) . Like many clinical conditions, the more assiduously one looks for it the more frequently it will be discovered. Ross (1965, personal communication) in a survey of 100 cases of carcinoma of the lung, found evidence of adrenal hyperplasia in 2%. While oat-cell carcinoma of the lung is the growth which most frequently causes this syndrome, it has been reported in patients with malignant disease at many other sites.
These patients do not show the typical clinical stigmata of Cushing's syndrome, probably because they usually die within a few weeks of the syndrome becoming established. There is much less obesity, osteoporosis and strim than in typical Cushing's syndrome. The presenting symptoms of the ectopic ACTH syndrome include cedema of the lower limbs, muscular weakness often made worse by diuretics, loss of tendon reflexes, periods of confusion, symptoms of diabetes mellitus including thirst and polyuria, and skin pigmentation.
The essential biochemical disturbance is an increase in circulating ACTH activity, and bioassays have shown such activity to be present in the primary tumour and in metastases, with subnormal amounts in the pituitary and none at all in non-tumourous tissue. The ACTH-like substance has close similarities to pituitary ACTH but it is quite likely that the active principle is a polypeptide of smaller size than the normal ACTH molecule.
There is a hypokalhmic alkalosis with a very high level of circulating cortisol, excessive loss of potassium in the urine, and loss of the normal diurnal cortisol variation.
The muscular weakness shown by these patients may be in part a result of the hypokalemia and in part a form of steroid myopathy. Hyponatrwmia: This has been described mainly in association with oat-cell carcinoma of the lung (Ross 1963), though cases have also occurred in association with tuberculosis, myxoedema and some brain disorders (including head injury, pituitary tumours, vascular disease and encephalitis). The clinical picture is a rather ill-defined one of increasing lethargy, confusion and drowsiness. Biochemically, the most striking abnormality is the hyponatramia, the serum Na being as low as 110 mEq/litre. This hyponatraemia is usually mainly of a dilutional type, the plasma volume being increased. The increased plasma volume reduces aldosterone secretion and hence there is a further loss of sodium so that the hyponatramia may become partly depletional as well as dilutional. Corresponding to the findings in the ectopic ACTH syndrome, in hyponatrwmia, antidiuretic (ADH) activity has been demonstrated in tumour tissue, and the syndrome appears to be due to an inappropriate secretion of a substance with ADH activity, this secretion continuing in spite of the dilutional hyponatramia.
The patients are improved by water restriction and particularly by treatment with 9-a-fludrocortisone. The use of cytotoxic drugs has occasionally produced improvement. Hypercalcawmia: While hypercalcemia in malignant disease is often due to the presence of bony metastases, it may occur in the absence of such bony deposits, particularly in association with primary carcinoma of the bronchus and hypernephroma. The main symptoms include malaise, thirst, polyuria and polydipsia and later vomiting and coma. Carey (1966) reported six cases of hypercalcemia without bony metastases in 100 consecutive cases of bronchial carcinoma. The hypercalcemia can be reversed by treatment with cortisone, and also when possible by removal of the primary tumour. The condition tends to recur if metastases develop later. CONCLUSION While many of the syndromes produced remotely by malignant disease are now well recognized, their pathogenesis remains obscure. It is necessary to explain, among other things, the variable time relationship between the growth and the remote effect; the independence of the size of the primary growth; and the fact that only a relatively small proportion of patients with malignant disease develop these interesting syndromes.
There is now good evidence that in the endocrine disturbances, the tumour secretes a substance with biochemical activity resembling naturally occurring hormones, and sometimes more than one such substance is produced. In progressive multifocal leukoencephalopathy, evidence of a virus infection is accumulating. In other forms of neuropathy the position is much less certain, and theories include virus infection, some autoimmune process and the secretion of a substance causing direct damage to neurones.
Although endocrine and neurological disorders do not frequently occur together in the same patient such associations are not unknown. Dermatomyositis has been described with hyponatremia (Williams 1963), and recently Hallpike & Morgan-Hughes (1966) have reported a patient with bronchial carcinoma who developed hyponatrnemia and myasthenia.
In peripheral sensorimotor neuropathy we have seen disturbances of glucose, sodium and potassium metabolism in individual patients as well as pigmentation due to secretion of melanocyte stimulating hormone (MSH).
It is not necessary to postulate that all of the diverse remote effects produced by carcinoma are the result of a single pathological process. Some may be found to be the result of a specific virus infection, while others have a purely hormonal basis. On the other hand it may be that in cases where a virus is incriminated, the neurological disturbance results from an abnormal response to a commonly occurring virus, the altered response being caused by some polypeptide secreted by the primary tumour.
Pathology by H Urich MD MRCP
The pathology of the remote effects of malignant neoplasms on the nervous and muscular systems is as varied and complex as their clinical picture, both in localization of the lesions and in the nature of pathological processes. The localization agrees fairly closely with the symptomatology, the nature of the processes on the other hand presenting many puzzling features. Those involving the central and peripheral nervous systems fall into four main groups: (1) Degenerative.
(2) Demyelinating. (3) Inflammatory. (4) Necrotizing.
Of the degenerative syndromes the subacute cerebellar degeneration is the best known (Greenfield 1934 , Brain et al. 1951 , Henson et al. 1954 , Brain & Wilkinson 1965 . The lesions consist of extensive disintegration and disappearance of Purkinje cells in the cerebellar cortex. Occasionally this cerebellar cortical atrophy may be associated with degeneration of the posterior columns and spinocerebellar tracts. Very rarely degenerative lesions in the globus pallidus and the subthalamic nucleus have also been reported.
Not enough material has as yet been examined of the recently described syndrome resembling motor neurone disease (Brain et a!. 1965). Of the four cases investigated so far only one resembled classical amyotrophic lateral sclerosis in that it showed severe degenerative changes both in the upper and the lower motor neurones, the latter largely confined to the lower brain stem and cervical cord. One case showed extreme loss of anterior horn cells throughout the cord without involvement of the upper motor neurone, in another there was prominent degeneration of the pyramidal tracts with minimal lesions in the anterior horns, and in the fourth case only mild loss of motor cells in the spinal cord was apparent.
In addition, in at least three cases degenerative changes were present in the posterior root ganglia with corresponding rarefaction of the posterior columns.
Demyelination in the central nervous system occurs in progressive multifocal leukoencephalo-
